Provided by Tiger Trade Technology Pte. Ltd.

Harvard Bioscience

7.48
-0.0700-0.93%
Volume:10.66K
Turnover:80.02K
Market Cap:34.05M
PE:-3.18
High:7.64
Open:7.64
Low:7.37
Close:7.55
52wk High:9.40
52wk Low:3.76
Shares:4.55M
Float Shares:3.55M
Volume Ratio:0.37
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3486
EPS(LYR):-12.8000
ROE:-89.95%
ROA:1.58%
PB:4.59
PE(LYR):-0.58

Loading ...

Harvard Bioscience Q1 Adj. EPS $(0.33) Beats $(0.62) Estimate, Sales $20.755M Miss $21.200M Estimate

Benzinga Earnings
·
May 12

Harvard Bioscience Q1 FY26 net loss narrows to $3.4 million; revenue falls 4.7% to $20.8 million

Reuters
·
May 12

BRIEF-Harvard Bioscience Q1 Revenue USD 20.755 Million

Reuters
·
May 12

Harvard Bioscience Announces First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 12

Harvard Bioscience Q1 EPS USD -0.77

THOMSON REUTERS
·
May 12

Harvard Bioscience Inc expected to post a loss of 62 cents a share - Earnings Preview

Reuters
·
May 08

Harvard Bioscience CEO, CFO to present at Sidoti Micro Cap Conference

Reuters
·
May 07

Harvard Bioscience schedules first-quarter earnings conference call

Reuters
·
Apr 28

Harvard Bioscience CFO Makes Bold Insider Move Signaling Confidence Ahead

TIPRANKS
·
Apr 02

Harvard Bioscience CFO Mark Frost acquires $25,000 common shares

Reuters
·
Apr 01

Harvard Bioscience Director William Snider Acquires USD 103,000 of Common Shares

Reuters
·
Mar 18

Harvard Bioscience CEO Makes Bold Insider Move With Fresh Stock Purchase

TIPRANKS
·
Mar 18

Harvard Bioscience CEO John D Duke acquires USD 25,050 of common shares

Reuters
·
Mar 18

Harvard Bioscience Is Maintained at Speculative Buy by Benchmark

Dow Jones
·
Mar 16

Harvard Bioscience Inc : Benchmark Raises Target Price to $6 From $0.60

THOMSON REUTERS
·
Mar 16

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM

Reuters
·
Mar 14

Harvard Bioscience trading halted, news pending

TIPRANKS
·
Mar 14

Harvard Bioscience Is Maintained at Speculative Buy by Benchmark

Dow Jones
·
Mar 13

Harvard Bioscience FY 2025 goodwill impairment hits USD 47.95 million as revenue falls 8% to USD 86.55 million

Reuters
·
Mar 13

Harvard Bioscience price target lowered to 60c from $2 at Benchmark

TIPRANKS
·
Mar 13